Recently, Hirai et al. presented a case exhibiting poor response after the administration of an EGFR TKI in a lung adenocarcinoma patient harboring both, the KIF5B-RET fusion gene and EGFR mutation [12]. The gene discussed is KIF5B; the disease is lung adenocarcinoma.